Overview
Julia Rotow is an Oncologist practicing medicine in Chestnut Hill, Massachusetts.
Dr. Rotow is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Lung Adenocarcinoma.
She is actively involved in clinical research, co-authoring 50 peer reviewed articles. Dr. Rotow is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Boylston St, Chestnut Hill, MA 02467
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Dana-Farber Cancer Institute
Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Frequently Asked Questions about Dr. Julia K. Rotow
How do I make an appointment with Dr. Julia K. Rotow?
You can book an appointment with Dr. Julia K. Rotow by calling their office at 617-632-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Julia K. Rotow a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julia K. Rotow is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Julia K. Rotow specialize in?
While Dr. Julia K. Rotow is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Julia K. Rotow participate in research or clinical trials?
Yes. Dr. Julia K. Rotow has published 50 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Julia K. Rotow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Julia K. Rotow accept my insurance?
Dr. Julia K. Rotow accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung CancerDr. Rotow isElite. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Rotow isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Rotow isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rotow isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rotow isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Rotow isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Rotow isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Rotow isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Lung NodulesDr. Rotow isExperienced. Learn about Lung Nodules.
- MesotheliomaDr. Rotow isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Rotow isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Rotow isExperienced. Learn about Metastatic Pleural Tumor.
- Neuroendocrine TumorDr. Rotow isExperienced. Learn about Neuroendocrine Tumor.
- Posterior Fossa TumorDr. Rotow isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)